Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Food Intake Response to Short-Term Modifications of Metabolism in Humans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02939404
Recruitment Status : Recruiting
First Posted : October 20, 2016
Last Update Posted : July 8, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) )

Brief Summary:

One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats.

Objectives:

To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.

Eligibility:

Healthy people ages 18-55.

Design:

Participants will stay at NIH for 20 days.

During the first 4 days, participants will have:

  • Medical exam
  • Electrocardiogram
  • Blood and urine tests. One blood test includes drinking a sugar solution.
  • DXA body composition scan
  • Questions about foods they like, physical activity, and personal behavior
  • Exercise test on a stationary bicycle

Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.

Some times, participants will eat a diet that matches their daily needs. Other times, they can eat as much as they wish from a vending machine.

Participants will have blood and urine collected.

Participants will swallow an ingestible wireless sensor and wear a small data recorder device.

On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.

Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.


Condition or disease
Healthy Volunteers

Detailed Description:
More than 30% of adults are considered overweight. In general, lifestyle changes (diet and exercise) or current weight loss drugs only lead to about 5 to 10% weight loss. This may be because a person s energy expenditure, aka the number of calories the body uses, leads to hunger and may increase the amount of food a person eats. Cold exposure is known to increase metabolism but it may not lead to weight loss if appetite and the desire for food are also increased. The primary goal of this study is to evaluate whether changing energy expenditure by cool temperature exposure results in changes in food intake. This study will involve a stay on our clinical research unit where we will determine the energy requirements (at 24 degree C) of 68 healthy, adult volunteers without evidence of diabetes. Exposure to cool temperatures (16 degree C) will be used to increase the number of calories a person s body uses in a day. Participants will spend 24 hours in a room that measures energy expenditure while the temperature in the room is turned down, once with a fixed diet and once with a buffet of food choices. After the fixed diet, volunteers will self-select how much food they wish to eat for one day from a vending machine. Volunteers will also spend one day fasting followed by a day self-selecting their food from the vending machine. Findings from this study will provide knowledge about a possible causal link between energy expenditure and eating behavior. This information may shed light on why many weight loss interventions that increase energy expenditure do not work as well as expected, and may eventually lead to new weight loss approaches and therapies.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 160 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans
Actual Study Start Date : April 27, 2017
Estimated Primary Completion Date : December 31, 2024
Estimated Study Completion Date : December 31, 2024

Group/Cohort
Volunteers
Healthy Volunteers



Primary Outcome Measures :
  1. To determine whether the effects of increased EE due to cool temperature exposure on energy intake are only concomitant with the increase in EE or persist until the following day. [ Time Frame: 7 yrs ]
  2. To investigate whether increases in EE lead to increased ad libitum food intake, as measured using a vending machine paradigm. [ Time Frame: 7 yrs ]

Secondary Outcome Measures :
  1. To determine whether 36 hrs of fasting will result in a change in energy intake on the following day, and to determine whether the decrease in 24h EE during fasting will correlate with amount of food consumed the following day. [ Time Frame: 7 yrs ]
  2. To determine if the interventions will alter the 24h respiratory quotient (RQ, an approximation for the ratio of carbohydrate-to-fat oxidation rates), and test whether the induced RQ changes independently contribute to the altered energy intake. [ Time Frame: 7 yrs ]
  3. To determine if the 24h EE responses to cool temperature exposure correlate with core body temperature or changes in peripheral skin temperatures, and to determine if these changes are related to body adiposity or associated with food intake. [ Time Frame: 7 yrs ]
  4. To assess if behavioral testing addressing dietary restraint, stress related eating behaviors, and executive function or the responses to visual analogue scales assessing hunger modify any observed EE to energy intake association. [ Time Frame: 7 yrs ]
  5. To assess whether the above behavioral testing as measured by previously validated questionnaires and tasks are associated with measured food intake or hormone concentrations. [ Time Frame: 7 yrs ]
  6. To assess if concentrations of appetitive or exercise-induced hormones will correlate with the observed changes in EE and energy intake. [ Time Frame: 7 yrs ]
  7. To determine if any observed association between EE and energy intake predicts future weight change at 6 months and 1 year. [ Time Frame: 7 yrs ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Volunteers
Criteria
  • INCLUSION CRITERIA:
  • Premenopausal women and men <55 years of age
  • Body weight <204 kg (<450 pounds) and >= 36 kg (>= 80 pounds)
  • Stable weight (variation <2.3 kg within past 6 months)
  • Ability to provide informed consent
  • Ability to follow verbal and written instructions
  • Ability to consume >95% of given food during the weight maintaining diet portions of the study
  • Healthy, as determined by medical history, physical examination, and laboratory tests

EXCLUSION CRITERIA:

  • Age <18 years
  • Weight greater than or equal to 204 kg (greater than or equal to 450 pounds, maximum weight of the iDXA machine as per manufacturer s manual), or weight <36 kg (<80 pounds, minimum weight allowed based on the NIH guidelines of blood drawing for research purposes)
  • Use of medications affecting metabolism and appetite in the last three months
  • Weight loss attempts in the past 6 months
  • Current use of tobacco products, marijuana, amphetamines, cocaine, or intravenous drug use
  • Current pregnancy, pregnancy within the past 6 months or lactation
  • History or clinical manifestation of:

    • Type 1 and Type 2 diabetes mellitus
    • History of surgery for the treatment of obesity
    • Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo and hyperthyroidism
    • Pulmonary disorders, including chronic obstructive pulmonary disease
    • Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
    • High blood pressure by sitting blood pressure measurement using an appropriate cuff higher than 140/90 mmHg on two or more occasions, or current antihypertensive therapy
    • Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 2x normal
    • Gastrointestinal disease including Crohn s disease, ulcerative colitis, celiac disease or other malabsorptive disorders
    • Abnormal kidney function (eGFR <60 mL/min/1.73m(2))
    • Central nervous system disease, including previous history of cerebrovascular accidents, dementia, neurodegenerative disorders or history of severe head trauma
    • Cancer requiring treatment in the past five years, except for nonmelanoma skin cancers or cancers that have clearly been cured
    • Infectious disease such as active tuberculosis, HIV (by self report), chronic coccidiomycoses or other chronic infections that might influence EE and weight
    • Diagnosis of binge eating disorder, anorexia and major psychiatric disorders based upon the DSM-IV including depression, schizophrenia and psychosis, which may impact the ability of the participant to be in the respiratory chamber for 24 hour time periods
  • Chronic ethanol use (more than 3 drinks/day)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02939404


Contacts
Layout table for location contacts
Contact: Paolo Piaggi, Ph.D. (602) 200-5306 paolo.piaggi@nih.gov

Locations
Layout table for location information
United States, Arizona
NIDDK, Phoenix Recruiting
Phoenix, Arizona, United States, 85014
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Layout table for investigator information
Principal Investigator: Paolo Piaggi, Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)